Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mazdutide on Coronary Plaque Progression in Overweight/Obese Patients
NCT07657676Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of mazdutide in Coronary atherosclerosis (CAD), obesity, sponsored by National Center for Cardiovascular Disease. Started Sep 2026; status: recruiting.
02
Drugs
mazdutide
03
Conditions
Coronary atherosclerosis (CAD)obesity
Beyond the preview
Go deeper on NCT07657676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657676.